CEL SCI Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

CEL SCI Stock Summary

CEL SCI competes with INmune Bio, Barinthus Biotherapeutics, Mersana Therapeutics, Aligos Therapeutics, and Kezar Life. CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company was incorporated in 1983 and is headquartered in Vienna, Virginia. Cel-Sci Corp operates under Biotechnology classification in the United States and is traded on AMEX Exchange.

CEL SCI Key Financial Ratios

CEL SCI Key Balance Sheet Accounts

CEL SCI Key Income Statement Accounts

CEL SCI Key Cash Accounts

CEL Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining CEL SCI's current stock value. Our valuation model uses many indicators to compare CEL SCI value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CEL SCI competition to find correlations between indicators driving CEL SCI's intrinsic value. More Info.CEL SCI Corp is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, CEL SCI's Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value CEL SCI by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

CEL SCI Corp Systematic Risk

Today, most investors in CEL SCI Stock are looking for potential investment opportunities by analyzing not only static indicators but also various CEL SCI's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of CEL SCI growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of CEL SCI help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of CEL SCI Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of CEL SCI Corp based on widely used predictive technical indicators. In general, we focus on analyzing CEL Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build CEL SCI's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CEL SCI Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CEL SCI. If investors know CEL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CEL SCI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of CEL SCI Corp is measured differently than its book value, which is the value of CEL that is recorded on the company's balance sheet. Investors also form their own opinion of CEL SCI's value that differs from its market value or its book value, called intrinsic value, which is CEL SCI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CEL SCI's market value can be influenced by many factors that don't directly affect CEL SCI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between CEL SCI's value and its price as these two are different measures arrived at by different means. Investors typically determine if CEL SCI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CEL SCI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.